We're proud to receive a 2025 CDMO Leadership Award in the “Small Molecule Dosage Form - Global" category.
When working with the right partner and network, transferring production between sites allows companies to reap a variety of strategic advantages. Timeline and cost efficiencies can be gained when a trusted CDMO can take a product from development to commercial launch. They can safeguard supply by producing at more than one site, and improve distribution by moving production closer to critical markets. They can also reduce program costs and risks by moving production to sites that are better qualified, can produce more economically, or are better positioned to meet the needs of regulators.
Listen to this webinar to hear industry experts, Derek Gallo, discuss: